Exelixis (EXEL) Tops Q4 EPS by 28c, Offers Guidance

Exelixis (NASDAQ: EXEL) reported Q4 EPS of $0.35, $0.28 better than the analyst estimate of $0.07. Revenue for the quarter came in at $451.1 million versus the consensus estimate of $352.78 million.

GUIDANCE:

Exelixis sees FY2022 revenue of $1.53-1.63 billion, versus the consensus of $1.63 billion.

For earnings history and earnings-related data on Exelixis (EXEL) click here.

You May Also Be Interested In

• WD-40 Co. (WDFC) Tops Q3 EPS by 76c; offers guidance
• VerticalScope invests $6.1M in Canadian AI firm AltaML
• ImmuCell reports 11.5% sales rise in Q2 2026, 20.9% gain for first half